Results per Page:
Viral immunologist taps ‘incredible potential’ of immune system
Dr. Paul Thomas will combine computational and empirical approaches to understand the immune repertoire and turn this knowledge into new diagnostic and therapeutic tools
RNA “typos” can highlight leukemia cells for immune attack
Looking beyond DNA, scientists find possible “surgically targeted” option for splicing factor-mutant blood cancers that lack effective immunotherapies
Immune cells vs. metastasis: ‘It’s a numbers game’
Fred Hutch scientists prevent metastasis by boosting cancer-killing T cells in patients
Learning the rules of the game behind lymphocyte diversity
From the Matsen Lab and Dr. Phil Bradley, Public Health Sciences Division
Subverting the immunoproteasome in acute myeloid leukemia
From the Chapuis and Greenberg Labs, Clinical Research Division
New computational method opens window into immune cell behavior
Approach links T-cell receptor genes to T-cell activity and function at single-cell resolution
Eight promising projects win Evergreen Fund grants to promote commercialization of research
A dozen scientists to receive up to $200K from 3-year-old Fred Hutch program
$12M NIH grant to study rare, aggressive skin cancer
Fred Hutch, UW researchers hope to improve immunotherapies for people with Merkel cell carcinoma
Decoding your immune system’s memories
Hutch researchers take a step toward reading the genetic record left by a lifetime of fighting disease
His immune system eradicated his melanoma. Could other patients’ bodies be taught to do the same thing?
How one man’s T cells are guiding the development of next-gen immunotherapies
A Q&A with immunotherapy researcher Dr. Rachel Perret
As part of a world-class immunotherapy research team, Perret is working her ‘dream job’ — trying to bring T-cell therapy to all who need it